Andrew Robbins

Overview

Andrew Robbins received an average of $8M in total compensation, including $494K in salary, at Cogent Biosciences from 2020 to 2023.

Source: SEC filings on April 23, 2024, April 25, 2023, and April 26, 2022.

Related executives

We found two more executives who work or worked at Cogent Biosciences.

Jessica Sachs

Cogent Biosciences

Chief Medical Officer

John Robinson

Cogent Biosciences

Chief Scientific Officer

News

You may also like